Cargando…

Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants

BACKGROUND: Chronic pain patients implanted with a neurostimulation device typically require follow-up and device programming visits to address changes in symptoms or treatment. Follow-up visits require access to specialty care and necessitate patients to take time off work, commute long distances,...

Descripción completa

Detalles Bibliográficos
Autores principales: Deer, Timothy R, Esposito, Michael F, Cornidez, Eric G, Okaro, Udoka, Fahey, Marie E, Chapman, Kenneth B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524179/
https://www.ncbi.nlm.nih.gov/pubmed/34703301
http://dx.doi.org/10.2147/JPR.S332966
_version_ 1784585459650789376
author Deer, Timothy R
Esposito, Michael F
Cornidez, Eric G
Okaro, Udoka
Fahey, Marie E
Chapman, Kenneth B
author_facet Deer, Timothy R
Esposito, Michael F
Cornidez, Eric G
Okaro, Udoka
Fahey, Marie E
Chapman, Kenneth B
author_sort Deer, Timothy R
collection PubMed
description BACKGROUND: Chronic pain patients implanted with a neurostimulation device typically require follow-up and device programming visits to address changes in symptoms or treatment. Follow-up visits require access to specialty care and necessitate patients to take time off work, commute long distances, arrange for travel, and/or work with a caregiver’s schedule. Telemedicine was adopted for some patient management as a result of the Sars-Cov-2 pandemic; however, remote optimization for neuromodulation still required an in-person visit to adjust device parameters. An FDA-approved digital platform enables remote programming of an implanted neuromodulation device using a real-time audio-video link from the clinical programmer to the patient controller. The Remote Optimization, Adjustment, and Measurement for Chronic Pain Therapy (ROAM-CPT) is a multi-center, prospective study that is currently underway to access the effectiveness of the teleprogramming system in fulfilling patients’ clinical demands. METHODS: This pilot study surveyed 16 patients to determine the ability of the teleprogramming platform to provide a rapid solution safely and effectively for patient’s chronic pain. Data were collected using a questionnaire that asked 6 clinician-centric questions and 5 patient-centric questions. RESULTS: 4/4 surveyed physicians were able to address patients’ needs. 16/16 surveyed patients reported a quick resolution to pain and 15/16 did not require additional follow-up. Data curated from this pilot study show that the teleprogramming application greatly improves patient care, is preferred by both clinicians and patients with minimal disruptions to patients’ everyday lives. CONCLUSION: Teleprogramming provides real-time virtual programming capabilities and optimizes patients’ therapy. PERSPECTIVE: This article describes remote device programming and analysis as an alternative to in-person programming/treatment sessions for neuromodulation patients. This remote option gives patients access to timely and clinically appropriate device management when in-person care may not be available.
format Online
Article
Text
id pubmed-8524179
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85241792021-10-25 Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants Deer, Timothy R Esposito, Michael F Cornidez, Eric G Okaro, Udoka Fahey, Marie E Chapman, Kenneth B J Pain Res Original Research BACKGROUND: Chronic pain patients implanted with a neurostimulation device typically require follow-up and device programming visits to address changes in symptoms or treatment. Follow-up visits require access to specialty care and necessitate patients to take time off work, commute long distances, arrange for travel, and/or work with a caregiver’s schedule. Telemedicine was adopted for some patient management as a result of the Sars-Cov-2 pandemic; however, remote optimization for neuromodulation still required an in-person visit to adjust device parameters. An FDA-approved digital platform enables remote programming of an implanted neuromodulation device using a real-time audio-video link from the clinical programmer to the patient controller. The Remote Optimization, Adjustment, and Measurement for Chronic Pain Therapy (ROAM-CPT) is a multi-center, prospective study that is currently underway to access the effectiveness of the teleprogramming system in fulfilling patients’ clinical demands. METHODS: This pilot study surveyed 16 patients to determine the ability of the teleprogramming platform to provide a rapid solution safely and effectively for patient’s chronic pain. Data were collected using a questionnaire that asked 6 clinician-centric questions and 5 patient-centric questions. RESULTS: 4/4 surveyed physicians were able to address patients’ needs. 16/16 surveyed patients reported a quick resolution to pain and 15/16 did not require additional follow-up. Data curated from this pilot study show that the teleprogramming application greatly improves patient care, is preferred by both clinicians and patients with minimal disruptions to patients’ everyday lives. CONCLUSION: Teleprogramming provides real-time virtual programming capabilities and optimizes patients’ therapy. PERSPECTIVE: This article describes remote device programming and analysis as an alternative to in-person programming/treatment sessions for neuromodulation patients. This remote option gives patients access to timely and clinically appropriate device management when in-person care may not be available. Dove 2021-10-14 /pmc/articles/PMC8524179/ /pubmed/34703301 http://dx.doi.org/10.2147/JPR.S332966 Text en © 2021 Deer et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Deer, Timothy R
Esposito, Michael F
Cornidez, Eric G
Okaro, Udoka
Fahey, Marie E
Chapman, Kenneth B
Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants
title Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants
title_full Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants
title_fullStr Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants
title_full_unstemmed Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants
title_short Teleprogramming Service Provides Safe and Remote Stimulation Options for Patients with DRG-S and SCS Implants
title_sort teleprogramming service provides safe and remote stimulation options for patients with drg-s and scs implants
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524179/
https://www.ncbi.nlm.nih.gov/pubmed/34703301
http://dx.doi.org/10.2147/JPR.S332966
work_keys_str_mv AT deertimothyr teleprogrammingserviceprovidessafeandremotestimulationoptionsforpatientswithdrgsandscsimplants
AT espositomichaelf teleprogrammingserviceprovidessafeandremotestimulationoptionsforpatientswithdrgsandscsimplants
AT cornidezericg teleprogrammingserviceprovidessafeandremotestimulationoptionsforpatientswithdrgsandscsimplants
AT okaroudoka teleprogrammingserviceprovidessafeandremotestimulationoptionsforpatientswithdrgsandscsimplants
AT faheymariee teleprogrammingserviceprovidessafeandremotestimulationoptionsforpatientswithdrgsandscsimplants
AT chapmankennethb teleprogrammingserviceprovidessafeandremotestimulationoptionsforpatientswithdrgsandscsimplants